The Harvard Stem Cell Institute (HSCI) Translational Program invites applications for Pilot Grant funding for 2012. The purpose of this funding program is to provide resources for proof-of-concept, preclinical research studies ultimately aimed at therapeutic clinical evaluation in humans to treat pediatric and adult disease.  These pilot grants are intended to foster the discovery phase of translational/pre-clinical research, in which possible therapeutic cellular products and their mechanism of action are explored in relevant animal and/or in vitro model systems.

N.B.: For an application to be accepted, the Principal Investigator on the proposal is required to personally attend a meeting at which Prof. Les Silberstein and Prof. Jerry Ritz will explain what is expected of this RFP. The meeting will take place Monday, March 26th 12:00 - 1:00, Karp building, 9th floor conference room, One Blackfan Circle, Boston. Please RSVP to claudia_rizzini@harvard.edu.

HSCI may fund up to two pilot grants in this round. Each project will be funded at a maximum of $83,333 in direct costs per year, and up to 20% (of total direct costs) in indirect costs (determined by institutional policy) for a period of two years.

To download the RFP, click here.